Table 2 LncRNA LOWEG expression and clinicopathological parameters of GC patients
Clinical parameters | N | Expression mean lncRNA LOWEG tumoral (± SD) | Expression mean lncRNA LOWEG marginal (± SD) | lncRNA LOWEG P-value |
|---|---|---|---|---|
Age | 0.313 | |||
 ≤ 50 | 43 | 0.052 (0.069) | 0.255 (0.363) |  |
 > 50 | 57 | 0.048 (0.079) | 0.201 (0.292) |  |
Gender | 0.333 | |||
 Male | 57 | 0.056 (0.074) | 0.250 (0.362) |  |
 Female | 43 | 0.041 (0.075) | 0.189 (0.266) |  |
Different tumor sizes | 0.425 | |||
 ≤ 5 cm | 30 | 0.055 (0.071) | 0.209 (0.252) |  |
 > 5 cm | 70 | 0.047 (0.076) | 0.231 (0.352) |  |
Lymph involvement | 0.895 | |||
 Negative | 27 | 0.044 (0.056) | 0.226 (0.262) |  |
 Positive | 73 | 0.052 (0.081) | 0.223 (0.346) |  |
TNM (Tumor stage) | 0.477 | |||
 Stage I and II | 67 | 0.048 (0.071) | 0.192 (0.307) |  |
 Stage III and IV | 33 | 0.054 (0.082) | 0.289 (0.352) |  |
Helicobacter pylori infection | 0.623 | |||
 Positive | 67 | 0.050 (0.069) | 0.213 (0.322) |  |
 Negative | 33 | 0.050 (0.086) | 0.248 (0.332) |  |
Lauren type | 0.942 | |||
 Intestinal | 76 | 0.055 (0.083) | 0.239 (0.344) |  |
 Diffuse | 24 | 0.055 (0.038) | 0.178 (0.253) |  |